Latest News and Press Releases
Want to stay updated on the latest news?
-
Block & Leviton is investigating BioAge Labs after the company discontinued its STRIDES Phase 2 trial for azelaprag. Investors should contact the firm.
-
Block & Leviton is investigating BioAge Labs, Inc. (Nasdaq: BIOA) for potential securities law violations. Investors should contact the firm to learn more.